Loading patent…
AssigneesThe Hong Kong Polytechnic University, Wayne State University, University of South Florida, McGill University
InventorsTak-Hang Chan, Wai-Har Lam, Larry Ming-Cheung Chow, Qing Ping Dou, Deborah Joyce Kuhn, Aslamuzzaman Kazi, Sheng Biao Wan, Kristin R. Landis-Piwowar
Estimating the term…
(−)-EGCG, the most abundant catechin, was found to be chemopreventive and anticancer agent. However, (−)-EGCG has at least one limitation: it gives poor bioavailability. This invention provides compounds of generally formulae below, wherein R11, R12, R13, R21, R22, R2, R3, and R4 are each independently selected from the group consisting of —H, and C1 to C10 acyloxyl group; and R5 is selected from the group consisting of —H, C1-C10-alkyl, C2-C10-alkenyl, C2-C10-alkynyl, C3-C7-cycloalkyl, phenyl, benzyl and C3 -C7 -cycloalkenyl, whereas each of the last mentioned 7 groups can be substituted with any combination of one to six halogen atoms; at least one of R11, R12, R13, R21, R22, R2, R3 and R4 is —H, which were found to be more potent than their non-protected counterparts, which can be used as proteasome inhibitors to reduce tumor cell growth.
A compound for inhibiting proteasome having the formula:
A method of reducing tumor cell growth including the step of administering an effective amount of a compound having the formula:
The use of a compound of having the formula:
A compound for inhibiting proteasome having the formula:
A method of reducing tumor cell growth including the step of administering an effective amount of a compound having the formula:
The use of a compound of having the formula:
Dependencies are inferred from the claim text.